HHS Awards $4.1 Million to Developer of Zika Blood Screening Test

"Accurate blood-screening tools are vital to protecting our nation's blood supply from Zika. This test may provide another tool laboratories can use to identify infected blood donations to help ensure patients' safety," said Dr. Richard Hatchett, BARDA's acting director. "At the same time, we are pursuing promising diagnostic tools and vaccines to identify and prevent Zika virus infections."

The U.S. Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response announced it has made a $4.1 million agreement with Hologic, Inc. of Marlborough, Mass., to advance the development of a blood screening test that will help detect the presence of Zika in the blood supply. HHS reported this is the second blood screening test ASPR's Biomedical Advanced Research and Development Authority, known as BARDA, is helping advance that may be used to test donated blood for Zika. In April, ASPR announced support of a clinical study of a Zika blood screening test developed by Roche Molecular Systems, Inc. to confirm whether that test accurately detects the virus in donors' blood.

"Accurate blood-screening tools are vital to protecting our nation's blood supply from Zika. This test may provide another tool laboratories can use to identify infected blood donations to help ensure patients' safety," said Dr. Richard Hatchett, BARDA's acting director. "At the same time, we are pursuing promising diagnostic tools and vaccines to identify and prevent Zika virus infections."

Under the one-year agreement, Hologic will advance the development of its Procleix Zika Virus Assay, which is designed to detect Zika virus ribonucleic acid in donated blood plasma. The contract could be extended up to a total of 18 months and $6.2 million to support a clinical study to evaluate the sensitivity and specificity of the blood donation screening test in actual use, which is necessary before it can be approved by the U.S. Food and Drug Administration for commercial marketing, if additional funding is identified for this activity.

The test was granted investigational new device status on June 17 by FDA.

Product Showcase

  • SwabTek® Cannabis Test Kit

    The SwabTek® Cannabis Test Kit is a single-use spot test designed for use in screening for cannabis compounds in any sample type or on any surface. The test is capable of identifying the presumed presence of cannabinoids in very small quantities, with a level of detection as little as 6 μg in mass. Learn more about the SwabTek® Cannabis Test Kit and the rest of SwabTek surface drug testing solutions through the webinar titled "Everything You Want To Know About Surface Testing" Read More

  • Full Line of Defense Against Combustible Dust Nilfisk

    Nilfisk provides a comprehensive range of industrial vacuums meticulously crafted to adhere to NFPA 652 housekeeping standards, essential for gathering combustible dust in Class I, Group D, and Class II, Groups E, F & G environments or non-classified settings. Our pneumatic vacuums are meticulously engineered to fulfill safety criteria for deployment in hazardous surroundings. Leveraging advanced filtration technology, Nilfisk ensures the secure capture of combustible materials scattered throughout your facility, ranging from fuels, solvents, and metal dust to flour, sugar, and pharmaceutical powders. Read More

  • Safety Shower Test Cart

    The Safety Shower Test Cart speeds up and simplifies emergency shower tests, ensures you stay in compliance with OSHA regulations, and significantly reduces testing costs. With 7 unique features, the cart makes testing easy, effective, and efficient. You can test water clarity, flow, temperature, and spread—all at the same time! Most safety shower testing kits create a mess, take too much time to use, and don't fully help you stay in compliance with OSHA & ANSI standards. Transform the way you test emergency showers with Green Gobbler Safety. Read More

Featured

Artificial Intelligence